QCG
ACLX

Quadrant Capital Group’s Arcellx ACLX Stock Holding History

Quadrant Capital Group’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61K Hold
14
– – ﹤0.01% 2536
2025
Q4 		$913 Hold
14
– – ﹤0.01% 2606
2025
Q3 		$1.15K Buy
+14
New +$1.01K ﹤0.01% 2549

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Quadrant Capital Group's ACLX Position: Q1 2026 in Review

Quadrant Capital Group held its Arcellx (ACLX) position steady in Q1 2026 at 14 shares worth $1.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2536.

Quadrant Capital Group first reported a position in ACLX in Q3 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Quadrant Capital Group held 14 shares of Arcellx worth $1.61K as of Q1 2026.
  • Quadrant Capital Group left its Arcellx share count unchanged in Q1 2026.
  • Arcellx made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2536 holding.
  • Quadrant Capital Group first reported a position in Arcellx in Q3 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.